| T0 | T1 | T2 | P | |||
---|---|---|---|---|---|---|---|
 | Group F | Group P | Group F | Group P | Group F | Group P |  |
MAP (mm Hg) | 53.1 (8.6) | 54.6 (10.7) | 62.9 (10.9) | 64.6 (14.0) | 65.7 (13.0) | 62.5 (11.2) | 0.99 |
IS | 0 (0) | 0 (0) | 9.5 (5) | 12.7 (9) | 8.7 (5) | 9.1 (6) | 0.374 |
Lactates (mM) | 1.0 (0.5) | 0.9 (0.5) | 3.3 (2.4) | 3.8 (2.5) | 1.6 (1.0) | 1.9 (1.5) | 0.433 |
ScvO2 (%) | 59.6 (16.6) | 59.8 (17.3) | 58.1 (15.0) | 59.0 (15.3) | 61.9 (16.0) | 56.7 (14.8) | 0.555 |
rSO2c (%) | 58.0 (12.1) | 58.6 (10.9) | 59.8 (15.3) | 56.9 (14.7) | 64.0 (9.3) | 63.5 (11.3) | 0.590 |
Diuresis (ml/kg/h) | 5.9 (5.2) | 6.9 (6.3) | 7.5 (6.7) | 6.8 (4.7) | 5.0 (2.5) | 4.7 (2.8) | 0.340 |
 | CPB phase |  |  |  |  | ||
 | Group F | Group P |  | ||||
CPB pressa (mm Hg) | 47.2 (4.7) | 49.0 (4.6) | 0.048 | ||||
Effective CPB flowa (ml/kg/min) | 151 (12.5) | 146.5 (16) | 0.142 | ||||
IDO2a (ml O2/min/m2) | 342.4 (50.1) | 331.7 (58.7) | 0.460 | ||||
ISVRa (dyn·s·cm-5/m2) | 404.9 (59.8) | 423.5 (97.2) | 0.502 |